These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22361420)

  • 21. Trial tests new combination of drugs to treat tuberculosis.
    Roehr B
    BMJ; 2012 Mar; 344():e2216. PubMed ID: 22434129
    [No Abstract]   [Full Text] [Related]  

  • 22. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
    J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doctors report breakthrough antibiotic treatment for TB.
    AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
    [No Abstract]   [Full Text] [Related]  

  • 24. Moxifloxacin versus ethambutol in initial tuberculosis treatment.
    Sellier P; Delcey V; Raskine L; Sanson-Le-Pors MJ; Bergmann JF
    Lancet; 2009 Jun; 373(9682):2198; author reply 2198-9. PubMed ID: 19560598
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
    Weiner M; Prihoda TJ; Burman W; Johnson JL; Goldberg S; Padayatchi N; Duran P; Engle M; Muzanye G; Mugerwa RD; Sturm AW
    J Clin Microbiol; 2010 Dec; 48(12):4370-6. PubMed ID: 20926712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hopkins scientist tunes in to treat tuberculosis.
    Bloom S
    J Clin Invest; 2005 Dec; 115(12):3302-3. PubMed ID: 16322772
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of moxifloxacin in tuberculosis regimen in a French teaching hospital].
    Berdot S; Papy E; Rioux C; Diamantis S; Ruimy R; Dombret MC; Arnaud P; Bouvet E
    Med Mal Infect; 2010 Oct; 40(10):568-73. PubMed ID: 20554138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
    Nuermberger E; Tyagi S; Williams KN; Rosenthal I; Bishai WR; Grosset JH
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1452-6. PubMed ID: 16151038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
    Burman WJ; Goldberg S; Johnson JL; Muzanye G; Engle M; Mosher AW; Choudhri S; Daley CL; Munsiff SS; Zhao Z; Vernon A; Chaisson RE
    Am J Respir Crit Care Med; 2006 Aug; 174(3):331-8. PubMed ID: 16675781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update in tuberculosis 2009.
    Daley CL
    Am J Respir Crit Care Med; 2010 Mar; 181(6):550-5. PubMed ID: 20208041
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tuberculosis: new treatment options and updated recommendations].
    Schaberg T
    Dtsch Med Wochenschr; 2013 Apr; 138(14):725-7. PubMed ID: 23533039
    [No Abstract]   [Full Text] [Related]  

  • 33. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
    Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
    Jiang RH; Xu HB; Li L
    Int J Antimicrob Agents; 2013 Jul; 42(1):36-41. PubMed ID: 23582696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensively drug-resistant tuberculosis.
    Dheda K; Shean K; Badri M
    N Engl J Med; 2008 Nov; 359(22):2390; author reply 2391. PubMed ID: 19038886
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecule of the Month. TMC-207.
    Drug News Perspect; 2009 Sep; 22(7):421. PubMed ID: 19890499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].
    Infection; 2012 Aug; 40 Suppl 1():1-71. PubMed ID: 22936293
    [No Abstract]   [Full Text] [Related]  

  • 38. Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.
    Lounis N; Veziris N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3543-7. PubMed ID: 16954317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A diarylquinolone active against tuberculosis].
    Holzgrabe U; Bennack E
    Pharm Unserer Zeit; 2005; 34(3):183-4. PubMed ID: 15940948
    [No Abstract]   [Full Text] [Related]  

  • 40. [R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].
    Lounis N; Guillemont J; Veziris N; Koul A; Jarlier V; Andries K
    Med Mal Infect; 2010 Jul; 40(7):383-90. PubMed ID: 19954909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.